10-Year watch begins for experimental spinal cord therapy
NCT ID NCT06163508
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study follows 9 people with transverse myelitis who previously received an experimental cell therapy called Q-Cells®. Researchers will monitor them for 10 years to check for side effects and see if the treatment continues to have any effect. Participants will have regular exams, lab tests, and imaging to ensure their safety.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSVERSE MYELITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Spinal cord repair: could cell injections restore function in transverse myelitis?
- Researchers hunt for clues: do our own antibodies harm nerves?
- Scientists launch major effort to unravel mysteries of rare brain and spinal cord diseases
- Pen and paper therapy: could expressive writing ease grief after spinal cord injury?
- Massive biobank launches to unlock secrets of MS and related disorders